glp-1 news today nov 2025 Pipeline Update: November - Prime Therapeutics GLP-1 Weight Loss Drug Enforcement
Description
The protective effect appeared particularly strong for endometrial cancer, ovarian cancer and meningioma.
There may also be an increase in strategic partnerships and acquisitions as companies look to bolster their portfolios with proven subq GLP-1 assets
Rhode Island's Medicaid agency proposes ending GLP-1 coverage for weight loss while keeping diabetes uses, citing soaring costs.
Literally. If youre taking a GLP-1 medication like semaglutide or tirzepatide and you feel like your digestion has slowed to a glacial pace, youre not alone
Start your journey to better health with Eden today.
Ozempic-era science keeps getting weirder
